Selleckchem Inc

Bio Active Compounds.

Recent products

Anti-IL-15 (DISC0280)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Nofazinlimab (Anti-PDCD1 / PD-1 / CD279)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anti-IL-13 (M1295)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Lebrikizumab (Anti-IL-13)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Anti-IL-13 (IMA-026)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anti-IL-13 (H2L6)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anti-IL-13 (GSK 679586)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Dectrekumab (Anti-IL-13)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Cendakimab (Anti-IL-13)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Nipocalimab (Anti-FcRn) (FCGRT & B2M)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Briakinumab (Anti-IL-12) (IL-12a & IL-12b)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Anti-IL-10 (BT-063)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anti-IGF2 (DX-2647)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Nimotuzumab (Anti-ERBB1 / EGFR / HER1)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Figitumumab (Anti-IGF1R / CD221)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Naptumomab (Anti-TPBG)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

1 661 662 663 705